Cargando…
The burden of neovascular age-related macular degeneration: a patient’s perspective
PURPOSE: To quantify the burden and quality of life of patients and their caregivers in a cohort of patients with neovascular age-related macular degeneration (nAMD) in an Australian clinical setting. METHODS: A total of 103 patients undergoing anti-vascular endothelial growth factor (VEGF) therapy...
Autores principales: | Spooner, Kimberly L, Mhlanga, Cleopatra T, Hong, Thomas H, Broadhead, Geoffrey K, Chang, Andrew A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287411/ https://www.ncbi.nlm.nih.gov/pubmed/30584267 http://dx.doi.org/10.2147/OPTH.S185052 |
Ejemplares similares
-
Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
por: Phan, Long T, et al.
Publicado: (2021) -
Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
por: Spooner, Kimberly, et al.
Publicado: (2017) -
Treatment of age-related neovascular macular degeneration: the patient’s perspective
por: Müller, S., et al.
Publicado: (2017) -
Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006) -
Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)